The FDA gives the green light for Helius Medical to proceed with enrollment for a clinical trial evaluating the company's Portable Neuromodulation Stimulator (PoNS) in the treatment of patients with balance problems due to brain injury.
The FDA gave the green light for Helius Medical Technologies to begin enrolling patients in a clinical trial of its portable neuromodulation stimulator in patients with chronic balance disorders due to mild-to-moderate brain injury.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1DeZWzD
Cap comentari:
Publica un comentari a l'entrada